Related Experiment Video
Updated: Feb 10, 2026

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Exploring the Role Of CD155 in Urothelial Carcinoma of the Urinary Bladder: An Immunohistochemical Study & Its
Passant Essam Shibel1, Aya Magdy Elyamany1, Galal El Shorbagy2
1Department of Anatomic Pathology, Faculty of Medicine, Cairo University, Egypt.
Background:
Urinary bladder carcinoma is one of the most immunogenic cancers. Several immune checkpoint inhibitors targeting programmed death-ligand 1 (PD-L1) have been approved by the FDA for bladder carcinoma treatment. However, additional immunotherapeutic targets are still needed. CD155 is another immune checkpoint molecule that has been shown to be overexpressed in several cancers and is associated with poor prognosis.
Aim:
This study aimed to evaluate CD155 expression in cases of urinary bladder urothelial carcinoma using immunohistochemistry and to correlate this expression with the clinicopathological parameters of the cases as well as with PD-L1 expression.
Methods:
Immunohistochemical staining for CD155 and PD-L1 was performed on 67 cases of urothelial carcinoma of the urinary bladder.
Results:
CD155 was positive in 41.8% of cases and was significantly associated with invasive tumors and advanced T stage. PD-L1 was positive in 35.8% of cases and was significantly associated with advanced T stage, distant metastasis, muscle invasion and lymphovascular emboli. A statistically significant positive correlation was observed between the expression of both CD155 and PD-L1.
Conclusion:
Our study demonstrated increased expression of CD155 in urothelial carcinoma of the urinary bladder with advancing stage, suggesting its potential as a therapeutic target. Additionally, CD155 expression correlated positively with PD-L1 expression, indicating that some patients might benefit from a combined blockade of both targets.
Insights
Increased CD155 expression in bladder cancer correlates with advanced stage and PD-L1. This suggests CD155 may be a therapeutic target, potentially benefiting patients with combined blockade of CD155 and PD-L1 (programmed death-ligand 1).
Area of Science:
- Oncology
- Immunology
- Urothelial Carcinoma Research
Background:
- Urinary bladder carcinoma is highly immunogenic, with approved immune checkpoint inhibitors targeting PD-L1 (programmed death-ligand 1).
- Novel immunotherapeutic targets are needed, as CD155 is an immune checkpoint molecule overexpressed in various cancers, linked to poor prognosis.
Purpose of the Study:
- To evaluate CD155 expression in urothelial carcinoma of the urinary bladder.
- To correlate CD155 expression with clinicopathological parameters and PD-L1 expression.
Main Methods:
- Immunohistochemical staining for CD155 and PD-L1.
- Analysis of 67 cases of urothelial carcinoma of the urinary bladder.
Main Results:
- CD155 positivity was observed in 41.8% of cases, significantly associated with invasive tumors and advanced T stage.
- PD-L1 positivity was observed in 35.8% of cases, associated with advanced T stage, metastasis, muscle invasion, and lymphovascular emboli.
- A significant positive correlation was found between CD155 and PD-L1 expression.
Conclusions:
- CD155 expression increases with advancing stage in urothelial carcinoma, indicating its potential as a therapeutic target.
- The positive correlation between CD155 and PD-L1 suggests that combined blockade of both targets may benefit certain patients.
Related Concept Videos
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Correlations
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:

